ARMATA PHARMACEUTICALS INC (ARMP) Stock Cash Flow
NYSEARCA:ARMP - NYSE Arca - US04216R1023 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -426.00K | -18.92M | -69.05M | -36.92M | -23.16M | |||
| Depreciation Amortization | 1.39M | 1.32M | 972.00K | 890.00K | 1.17M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.60M | -2.10M | -9.65M | 440.00K | -3.22M | |||
| Other non cash items | -33.90M | -17.86M | 30.30M | 3.11M | 1.63M | |||
| OPERATING CASH FLOW | -34.55M | -37.55M | -47.42M | -32.48M | -23.58M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.73M | -1.88M | -8.14M | -2.21M | -1.30M | |||
| Other Investing Activity | N/A | 0.00 | 10.00K | N/A | N/A | |||
| INVESTING CASH FLOW | -1.73M | -1.88M | -8.13M | -2.21M | -1.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 10.00M | 34.89M | 54.03M | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 130.00K | 5.00K | 44.52M | 26.93M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | -61.00K | -43.00K | -500.00K | -1.41M | |||
| FINANCING CASH FLOW | 10.01M | 34.96M | 53.99M | 44.02M | 25.52M | |||
| CHANGE IN CASH | -26.26M | -4.47M | -1.57M | 9.33M | 640.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -34.55M | -37.55M | -47.42M | -32.48M | -23.58M | |||
| Capital Expenditure | -1.73M | -1.88M | -8.14M | -2.21M | -1.30M | |||
| FREE CASH FLOW | -36.27M | -39.43M | -55.57M | -34.69M | -24.88M | |||
All data in USD